PHENYLEPHRINE HYDROCHLORIDE Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8859623 | PARAGON BIOTECK | Methods and compositions of stable phenylephrine formulations |
Nov, 2033
(9 years from now) | |
Phenylephrine Hydrochloride is owned by Paragon Bioteck.
Phenylephrine Hydrochloride contains Phenylephrine Hydrochloride.
Phenylephrine Hydrochloride has a total of 1 drug patent out of which 0 drug patents have expired.
Phenylephrine Hydrochloride was authorised for market use on 21 March, 2013.
Phenylephrine Hydrochloride is available in solution/drops;ophthalmic dosage forms.
Phenylephrine Hydrochloride can be used as dilation of the pupil.
The generics of Phenylephrine Hydrochloride are possible to be released after 14 November, 2033.
Drugs and Companies using PHENYLEPHRINE HYDROCHLORIDE ingredient
Market Authorisation Date: 21 March, 2013
Treatment: Dilation of the pupil
Dosage: SOLUTION/DROPS;OPHTHALMIC
More Information on Dosage
PHENYLEPHRINE HYDROCHLORIDE family patents
